protein and cell-based therapeutics

History:

The US subsidiary (BresaGen Inc.) which focused on stem cell research, merged with CyThera and Novocell (now called ViaCyte) in 2004. The Australian portion of the company was acquired by Hospira in 2004.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Other US Asia

Research Focus:
Other Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: